by admin_prosemble | 18th April 2025 | News
18 April 2025 – London, UK – Prosemble is honoured to have been selected by UKAI – the leading trade association representing UK AI businesses – to present its innovative protein nanoparticle and AI-driven technologies at the prestigious Healthcare and AI Showcase and...
by admin_prosemble | 17th April 2025 | News
17 April 2025 – London, UK – Prosemble is proud to announce its selection for the Cancer Tech Accelerator, a prestigious programme designed to support groundbreaking technologies with the potential to transform the early detection, diagnosis, monitoring, or treatment...
by admin_prosemble | 17th March 2025 | News, Research
A nice summary of our discovery, and how we are using it at Prosemble, from our “parent” institution, King’s College London: Newly identified bacterial protein to help with design of cancer drug delivery system | King’s College...
by admin_prosemble | 13th March 2025 | News
On Thursday, 13th March, Prosemble is honoured to be part of a select group of AI startups presenting at the very first Cambridge AI Demo Day. To put things into perspective: a major demo day is considered a huge success if it draws 30 investors. The Cambridge AI...
by admin_prosemble | 5th March 2025 | News
5th of March marked the final pitch day for as part of Prosemble AI in Health Accelerator Programme. Over the past eight weeks, we’ve taken a deep dive into customer discovery—constantly refining our understanding of the value we bring and what sets us apart. This...
by admin_prosemble | 4th March 2025 | News, Research
The peer-reviewed version of our paper reporting the structure of our tubular nanoparticles, is now out in PNAS! https://www.pnas.org/doi/10.1073/pnas.2500913122
